BCA
Bay Colony Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,238
| Closed | -$294K | – | 361 |
|
|
2023
Q2 | $294K | Buy |
8,238
+22
| +0.3% | +$784 | 0.07% | 241 |
|
|
2023
Q1 | $290K | Buy |
8,216
+403
| +5% | +$14.2K | 0.08% | 235 |
|
|
2022
Q4 | $275K | Buy |
+7,813
| New | +$275K | 0.07% | 265 |
|
|
2021
Q3 | – | Sell |
-13,223
| Closed | -$527K | – | 358 |
|
|
2021
Q2 | $527K | Sell |
13,223
-37
| -0.3% | -$1.48K | 0.18% | 160 |
|
|
2021
Q1 | $473K | Sell |
13,260
-177
| -1% | -$6.31K | 0.18% | 157 |
|
|
2020
Q4 | $494K | Buy |
13,437
+475
| +4% | +$17.5K | 0.26% | 118 |
|
|
2020
Q3 | $488K | Buy |
12,962
+5,172
| +66% | +$195K | 0.3% | 99 |
|
|
2020
Q2 | $318K | Buy |
+7,790
| New | +$318K | 0.23% | 128 |
|
|
2020
Q1 | – | Sell |
-10,335
| Closed | -$494K | – | 202 |
|
|
2019
Q4 | $494K | Buy |
10,335
+2,538
| +33% | +$121K | 0.32% | 110 |
|
|
2019
Q3 | $333K | Buy |
7,797
+1,524
| +24% | +$65.1K | 0.23% | 160 |
|
|
2019
Q2 | $251K | Buy |
6,273
+1,118
| +22% | +$44.7K | 0.16% | 175 |
|
|
2019
Q1 | $216K | Buy |
+5,155
| New | +$216K | 0.14% | 187 |
|
|
2018
Q3 | – | Sell |
-3,327
| Closed | -$134K | – | 476 |
|
|
2018
Q2 | $134K | Buy |
+3,327
| New | +$134K | 0.09% | 200 |
|